ZURICH, May 12 (Reuters) - Swiss drugmaker Roche has received the CE mark - a European regulatory clearance allowing sale in the region - for its second Elecsys blood test for Alzheimer's disease, it ...
Doctors and patients are gaining an edge in the fight against Alzheimer’s disease by catching early warning signs with new screening methods.
Simple blood tests can now detect Alzheimer's before symptoms appear, but most Americans cannot access them because Medicare ...
A new study offers fresh insight into Alzheimer's disease by looking beyond the brain and focusing on metabolic health, ...
1d
Using the body's own sounds to diagnose Alzheimer's and Parkinson's before the first symptoms appear
Long before the telltale signs of Parkinson's disease appear, including tremors and muscle stiffness, there are other, more ...
Elecsys® pTau217 is the first blood test for Alzheimer’s disease pathology with a single‑assay design, intended to rule in ...
A new study links regular egg consumption to a significantly lower risk of Alzheimer's disease, though experts caution the ...
Arginine reduced Alzheimer's plaques and improved memory in mice, offering hope for future medical treatments.
Findings suggest that egg consumption is associated with lower Alzheimer's disease risk, supporting the need for further ...
Alzheimer’s disease often starts its work long before anyone notices a problem. That gap, sometimes stretching a decade or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results